助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   高压症 在 消化系统疾病 分类中 的翻译结果: 查询用时:0.815秒
图标索引 在分类学科中查询
所有学科
消化系统疾病
外科学
临床医学
更多类别查询

图标索引 历史查询
 

高压症
相关语句
  hypertension
    Clinical Observation on the Splenic Transfer Factors in the Treatment of Portal Hypertension: Analysis of Nine Cases
    脾脏转移因子治疗门静脉高压症的临床观察(附9例分析)
短句来源
    Hemorheologic Observation on 45 Patients with Portal Hypertension
    45例门静脉高压症血液流变学的观察
短句来源
    Observation of the hemodynamics in patients with portal hypertension:(Ⅳ) Before and after the pericardial devascularigation combined with splenopneumopexy
    门静脉高压症的血流动力学观察──(Ⅳ)门奇断流术联合脾肺固定术前后
短句来源
    Segmental Portal Hypertension Caused by Splenic vein Thrombosis─14 Cases Report
    胰源性区域性门脉高压症──附14例报告
短句来源
    The Clinical Application of TIPSS in Treatment of Cirrhotic Portal Hypertension(CPH)
    TIPSS治疗肝硬化门脉高压症的临床应用
短句来源
更多       
  hypertension due
    Objective To investigate the association of G894T mutation of the endothelial nitric synthase (eNOS) gene at exon 7 with cirrhotic portal hypertension due to HBV infection in Chinese patients.
    目的 探讨内皮型一氧化氮合酶 (endothelialnitricoxidesynthase ,eNOS)基因第 7外显子G894T点突变与肝硬化门脉高压症之间的关系。
短句来源
    Objective To investigate the association of a variable number of tandem repeats (VNTR) polymorphism in intron 4 of the endothelial nitric synthase (eNOS) gene with cirrhotic portal hypertension due to HBV infection in Chinese population.
    目的 探讨内皮型一氧化氮合酶(eudnthelial nitric oxide synthase,eNOS)基因第4内含子数目可变性串联重复序列(variable number of tandem repeats polymorphism VNTR) 态性与肝硬化门脉高压症的相关性。
短句来源
    APPLICATION OF COLOR DOPPLER ULTRASOUND IN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT FOR THE PATIENTS WITH PORTAL HYPERTENSION DUE TO CIRRHOSIS
    彩色多普勒在经颈静脉肝内门体分流术治疗肝硬化门静脉高压症患者中的应用
短句来源
    So VEGF is an important reason during anamorphism of hepatocirrhosis. In this study, we observed expression of the mRNA of VEGF in wistar white rats' spleen in different period of hepatocirrhosis with in situ hybridization, and discovered the effect of VEGF in portal hypertension due to cirrhosis.
    本实验采用原位杂交法,测定肝硬化不同时期大鼠脾脏血管内皮细胞生长因子(VEGF)的 mRNA表达,以探讨血管内皮细胞生长因子在肝硬化门静脉高压症中的作用。
短句来源
    Fourteen cases of segmental portal hypertension due to splenic vein thrombosis are reported in this paper.
    本文报告了14例胰源性区域性门脉高压症
短句来源
更多       
  “高压症”译为未确定词的双语例句
    Evaluation of 99 mTC_MIBI rectum_portal imaging to assess the effect of propranolol on portal hypertention
    ~(99m)TC-MIBI直肠门脉显影评估普鲁纳洛治疗门脉高压症的疗效
短句来源
    Objective To investigate the expression of local TNF-α and angiotensinogen and activation of local nuclear factor-kappaB in vasculopathy of PHT and to discuss their role in the pathogenesis of portal hypertensive vasculopathy.
    目的探讨肝硬化门静脉高压症(portal hypertension,PHT)时局部肿瘤坏死因子-α(tumor necro-sis-alpha,TNF-α)、血管紧张素原与核因子-kappaB(nuclear factor-kappaB,NF-κB)在门静脉高压症性血管病变中的作用。
短句来源
    Conclusion: Plasma concentration of angiotensin Ⅱ is related to the progression of liver cirrhosis and the 1166A/C polymorphism of the AT1R gene is not related to hereditary susceptibility or progression of liver cirrhosis.
    结论:肝硬化患者血浆AngⅡ含量明显升高,并与肝硬化严重程度及门脉高压症的发生密切相关,AT1R 1166A/C基因多态性可能与乙肝肝硬化遗传易感性无关。
短句来源
    Methods The expression of VEGF and its receptor FLT-1,FLK-1 mRNA in 44 patients with PHG were analyzed by reverse transcription-polymerase chain reaction (RT-PCR).
    方法采用逆转录聚合酶链反应(RT-PCR)对44例肝硬化门静脉高压症患者PHG动态变化过程中病变部位的VEGF、FLT-1及FLK-1mRNA的表达进行检测。
短句来源
    Application of color doppler in treating Patients with portal hypertention by TIPS
    彩色多普勒在经颈静脉肝内门体分流术治疗肝硬化门静脉高压症患者中的应用
短句来源
更多       
查询“高压症”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  hypertension
We recognized and honoured the important contributions of these Chinese pioneers in portal hypertension, recurrent pyogenic cholangitis, hepatocellular carcinoma and liver transplantation.
      
Splenic autotransplantation and oesophageal transection anastomosis in patients with portal hypertension (26 years clinical obse
      
The surgical treatment methods for cirrhosis patients complicated with portal hypertension are complicated.
      
From 1979 to 2005, 274 cirrhosis patients with portal hypertension who underwent the new treatment strategy were followed up to observe different clinical indexes, which were then compared with those of the traditional surgery treatment.
      
Splenic auto transplantation and esophageal transection anastomosis are a safe, effective, and reasonable treatment strategy for portal hypertension with varicial bleeding.
      
更多          
  hypertension due
Moxonidine is a new centrally active imidazoline-receptor agonist being effectively applied in the treatment of arterial hypertension due to its sympathicolytic potency.
      
The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man
      
The clonidine patch offers for the first time the unique possibility of a once-a-week transdermal therapy of hypertension due to direct absorption of clonidine through the skin.
      
Patients with pulmonary venous hypertension due to extrinsic compression of the central pulmonary veins, or pulmonary veno-occlusive disease have few options, and treatment is generally palliative.
      
Pulmonary hypertension due to chronic thrombotic or embolic disease can be treated surgically, if the obstructive thrombi are proximal enough for the surgeon to resect them.
      
更多          


The author presents here 48 cases of portal hypertension treated with splenorenal shunt from 1974 to 1983. All of them were of the intrahepatic type. 20 cases underwent elective, 4 emergency and 24 prophylactic shunts. The average postshunt portal pressure decrement was 105 mmH2O. There were 4 postoperative deaths ( mortality 8.3% with 2 deaths in emergency, and none in the prophylactic shunt group). Over all follow-up rate was 95.5% (42 cases), and periods from 8 months to 9.6 years. 6 cases died within 1-...

The author presents here 48 cases of portal hypertension treated with splenorenal shunt from 1974 to 1983. All of them were of the intrahepatic type. 20 cases underwent elective, 4 emergency and 24 prophylactic shunts. The average postshunt portal pressure decrement was 105 mmH2O. There were 4 postoperative deaths ( mortality 8.3% with 2 deaths in emergency, and none in the prophylactic shunt group). Over all follow-up rate was 95.5% (42 cases), and periods from 8 months to 9.6 years. 6 cases died within 1- 6.8 years postoperatively. The absolute survival rates in 1, 3 and 5 years after operation were 93.2%, 78.5% and 72.7% respectively. There were 2 cases of rebleeding(4.8%) and 6 of encephalopathy (14.3%). Most of the ence-phalopathy cases responded well to protein restriction and intestinal antibiosis. The central splenorenal anastomosis is performed via the inferior margin of the pancreas by dissecting out the central segment of the splenic vein, which is then anastomosed to the left renal vein. The anastomosis thus made is near to the portal vein and the inferior vena cava. The operation is easy to perform giving a low incidence of re-bleeding and encephalopathy.

1974~1983年,我院采用中央型脾肾静脉分流术治疗肝内型门脉高压症48例,其中急症手术4例,择期手术20例,预防性分流术24例。术后近期死亡4例(有2例作急症分流),随访42例,最长9年8个月,平均为4年。远期死亡率14.3%,再出血率4.8%;脑病发生率14.3%;康复率88.9%;绝对生存率1、3及5年分别为93.2、78.5及72.7%。此术式系经胃结肠韧带切开的途径暴露胰腺体部,掀起胰体前下缘,游离胰体后脾静脉中央段,使之与肾静脉吻合,优点为操作简便、出血少、吻合口较大血流通畅、降压效果好,平均降压105mmH_2O,再出血率较低,分流量因受肾静脉容量限制,故门脉血流对肝灌注影响不太大,脑病发生率未高出周围型脾肾静脉分流术。

Measuring the widths of the portal vein and splenic veins could be achieved by B-

本文报告也用B 型超声测量门静脉、脾静脉宽度对门脉高压症的诊断价值。结果分析表明慢性肝炎、肝硬化不伴食道静脉曲张与肝硬化伴食道静脉曲张三组,其门、脾静脉宽度逐级增加;食道静脉关。曲张越严重,门、脾静脉亦越宽;有腹水者门静脉较无腹水者为宽;门脾静脉宽度与脾肿大均无相本文资料显示,如B 型超声测量门静脉宽度≥13mm,脾侧脾静脉宽度≥7.4mm,即可作出门脉高压的初步诊断。

It has been confirmed that regulation of hepatic microvascular beds is mainly controlled by alpha-adrenoceptors. In order to clarify whether alpha-adre-noceptor antagonists arrest the effects of alpha-adrenoceptors on hepatic vascular beds and decrease the pressure of portal vein and w dged hepatic vein in liver cirrhosis, we observed the effect of alpha-adrenoceptor antagonist, (phentolamine, perfused intravenously) on aforementioned pressure in liver cirrhosis induced by dimethyni-trosamine or common bile...

It has been confirmed that regulation of hepatic microvascular beds is mainly controlled by alpha-adrenoceptors. In order to clarify whether alpha-adre-noceptor antagonists arrest the effects of alpha-adrenoceptors on hepatic vascular beds and decrease the pressure of portal vein and w dged hepatic vein in liver cirrhosis, we observed the effect of alpha-adrenoceptor antagonist, (phentolamine, perfused intravenously) on aforementioned pressure in liver cirrhosis induced by dimethyni-trosamine or common bile duct ligation in dogs (n = 6). The experimental results show that phentolamine can markedly reduce portal venous pressure, wedged hepatic venous pressure and hepatic venous pressure gradient on average to 35.2%, 37.2%, 52.1%; P<0.01 respectively.

本实验成功地建立了狗肝硬变门脉高压症模型,观察了α~受体拈抗剂(酚妥拉明)对狗肝硬变门脉压、肝静脉嵌塞压和肝静脉压力梯度的作用。实验结果表明,酚妥拉明能明显降低狗肝硬变的门脉压、肝静脉嵌塞压和肝静脉压力梯度,分别下降35.2%、37.2%和52.1%。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关高压症的内容
在知识搜索中查有关高压症的内容
在数字搜索中查有关高压症的内容
在概念知识元中查有关高压症的内容
在学术趋势中查有关高压症的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社